×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Molecular Templates, Inc. Provides Interim Update
GlobeNewswire
Molecular Templates, Inc. Provides Interim Update · Monotherapy activity with PD-L1-targeting MT-6402 in Head and Neck Cancer; Unique...
2 months ago
Little Excitement Around Molecular Templates, Inc.'s (NASDAQ:MTEM) Revenues As Shares Take 48% Pounding
Simply Wall Street
Little Excitement Around Molecular Templates, Inc.'s (NASDAQ:MTEM) Revenues As Shares Take 48% Pounding ... Molecular Templates, Inc. (NASDAQ:MTEM)...
1 month ago
Molecular Templates, Inc. Reports Third Quarter 2023 Financial Results and Business Update
Yahoo Finance
MT-6402 Dose Escalation (Part A) Head & Neck Patients (N=8) AUSTIN, Texas, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Molecular Templates,...
5 months ago
Molecular Templates Inc Announces Layoffs, CMO Resignation - TipRanks.com
Tipranks
Molecular Templates Inc (MTEM) has shared an announcement. Molecular Templates, Inc. is cutting its workforce by 30% to conserve resources...
3 weeks ago
What's Going On With Molecular Templates Stock? - Molecular Templates (NASDAQ:MTEM)
Benzinga
Molecular Templates shares are volatile Tuesday after the company presented interim data from MT-6402 Phase I study in patients with PD-L1+...
3 weeks ago
More layoffs at Molecular Templates as biotech pays off debts to keep show on the road
Fierce Biotech
The biotech has announced another wave of layoffs, with 44% of the remaining staff set to go as part of a new restructuring plan.
10 months ago
Molecular Templates, Inc. Reports Fourth Quarter 2023 Financial Results and Business Update
FOX40
AUSTIN, Texas, March 29, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”),...
1 month ago
Molecular Templates reports progress in cancer therapy trial By Investing.com
Investing.com
AUSTIN, Texas - Molecular Templates, Inc. (NASDAQ:MTEM), a clinical-stage biopharmaceutical company, has presented interim data at the...
3 weeks ago
Top 5 Health Care Stocks Which Could Rescue Your Portfolio In March
markets.businessinsider.com
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
1 month ago
Molecular Templates Announces the Appointment of Dr. Maurizio Voi to the Role of Chief Medical Officer
ConchoValleyHomepage.com
AUSTIN, Texas, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”),...
7 months ago